NEWSNATIONNOW (Rob Taub) - GLP-1 drugs linked to boosting testosterone, sperm count in men
New research suggests GLP-1 drugs may improve male fertility by boosting testosterone and sperm health in men with obesity.
NEWSNATIONNOW (Jordan Perkins) - Could stopping and restarting GLP-1 drugs have side effects?
A study found that stopping and restarting GLP-1s could make the drug less effective in weight loss.
NYTIMES (Dani Blum) - GLP-1 Drugs: 6 Things We’ve Learned About Their Effects
The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects.
ABCNEWS - Doctor explains study showing GLP-1s may lower breast cancer risk
A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast cancer by about 30%.
NYTIMES (Gina Kolata) - Scientists Find a Potential Cure for Chronic Hepatitis B
Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these patients.
NEWSNATIONNOW (Rob Taub) - GLP-1 drugs linked to reduced cancer progression, study finds
The findings suggest GLP-1 drugs have anti-inflammatory and anti-tumor effects.
NYTIMES (Apoorva Mandavilli) - A Single Infusion Could Suppress H.I.V. for Years, Study Suggests
A study of a few patients, to be presented this week, showed promise for a type of therapy that has already cured some blood cancers.
NEWSNATIONNOW (Jordan Perkins) - GLP-1s and hair loss: Study finds a new link
The study found that hair loss was strongest among people who were taking higher doses of GLP-1s for weight loss.
NEWSNATIONNOW (Natasha Zouves) - Dr. Oz backs psychedelics as potential therapies: 'Tantalizing evidence'
Natural psychoactive compounds have gained traction as possible treatments for mental illnesses, brain injuries, dementia and addictive behaviors.
NPR (Yuki Noguchi) - Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it
A majority of people who start the obesity and diabetes medicines known as GLP-1s also quit them, and plan to restart again. Research hasn't yet shown the health impacts of cycling on and off the drugs.